Table 2 Baseline characteristics of participants without a history of acute myocardial infarction or stroke, categorized by sex data are presented as the means ± the standard deviations or the frequencies and proportions.

From: Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes

 

All

(n = 1,854,264)

Men

(n = 1,053,645)

Women

(n = 800,619)

P-value

Age (yrs)

56 ± 11

55 ± 10

57 ± 11

< 0.001

Diabetes, n (%)

673,688 (36.3)

383,665 (36.4)

290,023 (36.2)

0.008

Current smoking, n (%)

431,644 (23.3)

405,207 (38.5)

26,437 (3.3)

< 0.001

Heavy drinking, n (%)

373,190 (20.1)

310,274 (29.5)

62,916 (7.9)

< 0.001

Physical activity, n (%)

  None

934,624 (50.4)

464,898 (44.1)

469,726 (58.7)

< 0.001

  1 time/week

440,171 (23.7)

294,805 (28.0)

145,366 (18.2)

 

  ≥ 2 times/week

479,469 (25.9)

293,942 (27.9)

185,527 (23.2)

 

Lipid-lowering therapy, any (%)

287,757 (15.5)

134,228 (12.7)

153,529 (19.2)

< 0.001

Antihypertensive agents, any (%)

563,468 (30.4)

295,563 (28.1)

267,905 (33.5)

< 0.001

History of heart failure, n (%)

12,679 (0.7)

4,444 (0.4)

8,235 (1.0)

< 0.001

Menopause, n (%)

  

391,666 (48.9)

 

Body mass index (kg/m2)

24.54 ± 4.78

24.55 ± 4.09

24.52 ± 5.56

< 0.001

Systolic blood pressure (mmHg)

127 ± 16

128 ± 15

126 ± 16

< 0.001

Diastolic blood pressure (mmHg)

79 ± 10

80 ± 10

77 ± 10

< 0.001

Fasting glucose (mg/dL)

120 ± 33

121 ± 34

117 ± 30

< 0.001

Total cholesterol (mg/dL)

204 ± 45

200 ± 45

208 ± 45

< 0.001

Triglycerides (mg/dL)

157 ± 112

172 ± 124

138 ± 89

< 0.001

HDL cholesterol (mg/dL)

54 ± 28

53 ± 26

57 ± 30

< 0.001

LDL cholesterol (mg/dL)

120 ± 87

116 ± 92

126 ± 79

< 0.001

eGFR (mL/min/1.73 m2)

84 ± 17

85 ± 16

83 ± 17

< 0.001

  1. HDL cholesterol, High-density lipoprotein cholesterol; LDL cholesterol, low-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate.